Xiaoli Lü
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Ion Transport and Channel Regulation
Papers in
-
- RNA Interference and Gene Delivery 4
- Renal and related cancers 2
- Genetics 7
- Virus-based gene therapy research 4
- Co-authors
- Paul D. Robbins (5 shared papers)Zhibao Mi (4 shared papers)Gilbert Arthur (7 shared papers)Feimin Zhang (4 shared papers)Wenxiang Wang (3 shared papers)Michael C. Gorry (1 shared paper)Patricia Hart (1 shared paper)Tom C. Hart (1 shared paper)
- Journals
- The FASEB Journal (2 papers)Biochemical Journal (2 papers)Toxicology Letters (2 papers)Molecular Therapy (2 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaoli Lü
46 papers receiving 758 citations
Peers
Comparison fields: 5 of 101
- Cancer Research 84
- Molecular Biology 393
- Oncology 92
- Genetics 94
- Health, Toxicology and Mutagenesis 46
Countries citing papers authored by Xiaoli Lü
This map shows the geographic impact of Xiaoli Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Lü more than expected).
Fields of papers citing papers by Xiaoli Lü
This network shows the impact of papers produced by Xiaoli Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Lü. The network helps show where Xiaoli Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 122 | |
| 2 | 2003 | 61 | |
| 3 | 2007 | 57 | |
| 4 | 2003 | 52 | |
| 5 | 2014 | 50 | |
| 6 | 2008 | 45 | |
| 7 | 2020 | 39 | |
| 8 | 2012 | 29 | |
| 9 | 2013 | 27 | |
| 10 | 2021 | 27 | |
| 11 | 2012 | 25 | |
| 12 | Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines. | 1992 | 23 |
| 13 | 2012 | 20 | |
| 14 | Preliminary characterization of Pepino Mosaic Virus Shanghai isolate (PepMV-Sh) and its detection with ELISA. | 2003 | 18 |
| 15 | 2019 | 17 | |
| 16 | 2017 | 15 | |
| 17 | 2018 | 14 | |
| 18 | 1998 | 14 | |
| 19 | 2021 | 13 | |
| 20 | 2015 | 13 |
About Xiaoli Lü
Xiaoli Lü is a scholar working on Molecular Biology, Genetics, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 50 papers that have together received 780 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (4 papers), Virus-based gene therapy research (4 papers), Bone Tissue Engineering Materials (3 papers), Cancer-related molecular mechanisms research (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Lipid metabolism and biosynthesis (3 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Cancer Research (84 citations), Molecular Biology (393 citations), Oncology (92 citations), Genetics (94 citations) and Health, Toxicology and Mutagenesis (46 citations). Xiaoli Lü has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Paul D. Robbins, Zhibao Mi, Gilbert Arthur, Feimin Zhang, Wenxiang Wang, Michael C. Gorry, Patricia Hart, Tom C. Hart, Wenchang Zhang and N. P. Piesco. Their work appears in journals such as The FASEB Journal, Biochemical Journal, Toxicology Letters, Molecular Therapy and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.